De Burlo Group’s Biogen BIIB Stock Holding History

De Burlo Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-125	Closed	-$33.4K	–	90
2022 Q3	$33.4K	Buy	+125	New	+$26.5K	0.01%	113
2022 Q2	–	Sell	-125	Closed	-$26.3K	–	100
2022 Q1	$26.3K	Buy	+125	New	+$27.2K	﹤0.01%	123
2015 Q3	–	Sell	-22,315	Closed	-$9.01M	–	102
2015 Q2	$9.01M	Sell	22,315 -2,100	-9%	-$843K	1.89%	15
2015 Q1	$10.3M	Buy	24,415 +1,530	+7%	+$603K	2.04%	14
2014 Q4	$7.77M	Sell	22,885 -1,525	-6%	-$493K	1.57%	20
2014 Q3	$8.07M	Sell	24,410 -3,700	-13%	-$1.22M	1.79%	21
2014 Q2	$8.86M	Sell	28,110 -14,670	-34%	-$4.42M	2.01%	19
2014 Q1	$13.1M	Sell	42,780 -2,790	-6%	-$886K	3.16%	3
2013 Q4	$12.7M	Buy	45,570 +2,720	+6%	+$704K	3.04%	4
2013 Q3	$10.3M	Hold	42,850	–	–	2.81%	6
2013 Q2	$9.22M	Buy	+42,850	New	+$9.16M	2.73%	7

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

De Burlo Group's BIIB Position: Q4 2022 in Review

De Burlo Group sold out of Biogen (BIIB) in Q4 2022, closing a stake of 125 shares — an estimated $33.4K sold.

De Burlo Group first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $13.1M in Q1 2014. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

De Burlo Group reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
De Burlo Group sold 125 Biogen shares in Q4 2022, an estimated $33.4K.
De Burlo Group first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
De Burlo Group's Biogen position peaked at $13.1M in Q1 2014.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on De Burlo Group's 13F filing for Q4 2022, filed 14 Feb 2023.